Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C544308
http://purl.bioontology.org/ontology/MESH/C544308
|
|---|---|
| Preferred Name | GSK 1070916 |
| Synonyms |
4-(3-(4-N,N-dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl)-2-(3-(dimethylaminomethyl)phenyl)-1H-pyrrolo(2,3-b)pyridine
GSK-1070916
GSK1070916
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | 4-(3-(4-N,N-dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl)-2-(3-(dimethylaminomethyl)phenyl)-1H-pyrrolo(2,3-b)pyridine
GSK-1070916
GSK1070916
|
|---|---|
| prefLabel | GSK 1070916
|
| II | D047428
|
| Scope Statement | an antineoplastic agent with aurora B/C kinase inhibitory activity
|
| type | |
| tui |
T109
T121
|
| HM |
D007211
D001372
|
| SC | 1
|
| TERMUI |
T772946
T759603
T759602
T759601
|
| TH |
NLM (2009)
NLM (2010)
|
| SRC | Mol Cancer Ther 2009 Jul;8(7):1808-17
|
| MMR | 20131024
|
| notation | C544308
|
| Semantic type UMLS property | |
| cui |
C2931938
C2743471
|
| MeSH Frequency | 11
|
| DSC | 20091016
|
| Inverse of RB | 0
|
| Mapped to | |
| MDA | 20091016
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |